# Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma

> **NCT00487305** · PHASE1 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 24 (actual)

## Conditions studied

- Follicular Lymphoma

## Interventions

- **BIOLOGICAL:** Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells

## Key facts

- **NCT ID:** NCT00487305
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2023-07-25
- **Final completion:** 2023-07-25
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00487305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00487305, "Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00487305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*